Seeking Alpha

Acura Pharmaceuticals (ACUR +47.9%) shares skyrocket ~50%, apparently due to a report from...

Acura Pharmaceuticals (ACUR +47.9%) shares skyrocket ~50%, apparently due to a report from EMPR.com that its Nexafed drug will be available soon. Nexafed is an immediate-release next generation pseudoephedrine tablet which combines nasal congestion relief with ACUR's IMPEDE technology that disrupts the conversion of pseudoephedrine into methamphetamine.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|